This is a randomised, multi-center, open label, adaptive, exploratory trial to assess the
efficacy of two different drug regimens in terms of preventing symptomatic COVID-19 disease
in healthcare workers at high risk of exposure to SARS-CoV-2. The trial will compare two
different experimental medication arms to the control arm comprising the use of standard
personal protective equipment (PPE) with no additional pharmacological intervention.